Apex Critical Metals Corp
F:KL9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Apex Critical Metals Corp
F:KL9
|
CA |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
FR |
|
K
|
KGL Resources Ltd
F:KN6
|
AU |
|
K
|
KGL Resources Ltd
XMUN:KN6
|
AU |
|
H
|
Heidelberg Pharma AG
F:HPHA
|
DE |
|
T
|
Tudor Gold Corp
OTC:TDRRF
|
CA |
|
V
|
Vonovia SE
MIL:VNA
|
DE |
|
Ringkjoebing Landbobank A/S
F:CJ2
|
DK |
|
A
|
AES Corp
F:AES
|
US |
|
C
|
Compagnie De l'odet SE
SWB:49F
|
FR |
|
F
|
Flotek Industries Inc
F:F2I
|
US |
Shareholder Yield
Current shareholder yield for KL9 is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
KL9 Price
Apex Critical Metals Corp
| Average Annual Return | 207.51% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -74% |
| Market Capitalization | 138.8m EUR |
| Shares Outstanding | 70 690 000 |
| Percentage of Shares Shorted |
N/A
|
KL9 Return Decomposition
Main factors of price return
Stock Splits
KL9's latest stock split occurred on Nov 7, 2024
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
Before the split, KL9 traded at 0.62 per share. Afterward, the share price was about 0.44.
The adjusted shares began trading on Nov 7, 2024. This was the only stock split in KL9's history.